Patent · US Active

Antibodies binding to IL-17A

US9512217B2 · kind B2 · utility

0Cited by
7References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 6, 2014
Grant dateDec 6, 2016
Priority date
Expiry dateJan 6, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.